MarketPeel
Insider Trading Intelligence
JL

Julie Larson-green

HCAT
DIRECTOR · HEALTH CATALYST, INC. · CIK 0001796545
FILING MIX · LIFETIME94%/6%
BUYS
16
SELLS
1
TOTAL VALUE
$128.3K
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
94,644
AVG SELL PX
$2.67
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Julie Larson-green, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-4.83%+0.70%-5.53%-5.53%
14d1+100.00%-11.90%-1.16%-10.74%-10.74%
30d1+100.00%-15.24%-0.18%-15.06%-15.06%
60d1+100.00%-14.50%+1.61%-16.11%-16.11%
90d1+100.00%-27.51%+0.11%-27.62%-27.62%
180d1+100.00%-48.70%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HCAT · 94,644 shares · as of Jun 1, 2026
030,39360,78591,178121,570202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 1 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
12,71094,644Jun 1, 2026Jun 3, 2026View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
8,36181,934Mar 1, 2026Mar 5, 2026View →
HCAT
HEALTH CATALYST, INC.
SALE
47,997$2.67$128.3K73,573Dec 4, 2025Dec 8, 2025View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
5,731121,570Dec 1, 2025Dec 3, 2025View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
4,588115,839Sep 1, 2025Sep 5, 2025View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
36,231111,251Jul 9, 2025Jul 10, 2025View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
3,76675,020Jun 1, 2025Jun 3, 2025View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
2,45071,254Mar 1, 2025Mar 4, 2025View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
1,61668,804Dec 1, 2024Dec 3, 2024View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
1,95067,188Sep 1, 2024Sep 10, 2024View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
20,80765,238Jun 13, 2024Jun 17, 2024View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
12,50539,295Jun 14, 2023Jun 16, 2023View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
5,13644,431Jun 14, 2023Jun 16, 2023View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
11,67726,790Jun 14, 2022Jun 16, 2022View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
3,28515,113Jun 10, 2021Jun 14, 2021View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
5,44311,828Jun 12, 2020Jun 17, 2020View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
6,3856,385Feb 7, 2020Feb 11, 2020View →
Other insiders · HCAT
Loading peer insiders…
About this filer
CIK 0001796545
ROLE
Director
PRIMARY
HCAT
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001796545DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback